# US 2019/0314034 A1 · Neurovascular occlusion device

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0314034 A1
- Document ID: US20190314034A1
- Status: Published application
- Kind: A1
- Application number: 16/454,943
- Filed: 2019-06-27
- Published: 2019-10-17
- Earliest claimed: 2015-09-24
- Assignees: Embolic Acceleration, LLC
- Applicants: Embolic Acceleration, LLC
- Inventors: Andrew H. Cragg; John Logan; Brett E. Naglreiter; Alejandro Espinosa
- Web page: https://patentgrep.com/patent/US20190314034A1

## CPC

- A61B 17/12145: {having a pre-set deployed three-dimensional shape (methods of manufacturing A61B2017/00526)}
- A61B 17/12022: {Occluding by internal devices, e.g. balloons or releasable wires (plugging an opening in the wall of an organ A61B17/0057; occluders for the cervical canal A61F6/146; vas deferens occluders A61F6/20)}
- A61B 17/12031: {complete occlusion}
- A61B 17/12109: {in a blood vessel}
- A61B 17/12172: {having a pre-set deployed three-dimensional shape (methods of manufacturing A61B2017/00526)}
- A61B 17/12177: {comprising additional materials, e.g. thrombogenic, having filaments, having fibers or being coated}
- A61B 90/39: {Markers, e.g. radio-opaque or breast lesions markers}
- A61B 2017/00867: {shape memory effect}
- A61B 2017/12054: {Details concerning the detachment of the occluding device from the introduction device}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

A neurovascular occlusion device for occluding a vessel and a delivery system for delivering the occlusion device. The occlusion device can include a self-expandable support structure defining a concave occlusive component and an anchoring component separated by a neck component. The occlusive component can carry a functionally occlusive membrane configured to prevent substantially all fluid from flowing past the occlusion device when the occlusion device is expanded in the vessel.

## Claims

### Claim 1

A neurovascular occlusion device for occluding blood flow in a vessel, comprising:
a support structure, self-expandable from a reduced cross-section for transluminal navigation to an enlarged cross-section for occluding a vessel, the support structure defining a concave occlusive component and an anchoring component separated by a neck component, the anchoring component comprising a ring of cells, the ring of cells comprising a first cell and a circumferentially adjacent second cell, a length of the first cell in a longitudinal direction being greater than a length of the second cell in the longitudinal direction.

### Claim 2 (depends on 1)

The neurovascular occlusion device of claim 1, wherein the ring of cells comprises a third cell circumferentially adjacent the second cell, the length of the second cell in the longitudinal direction being shorter than a length of the third cell in the longitudinal direction.

### Claim 3 (depends on 1, 2)

The neurovascular occlusion device of claim 1 or 2, wherein the occlusive component comprises a ring of cells, each cell in the at least one ring having a same length.

### Claim 4

The neurovascular occlusion device of any one of the preceding claims, wherein nodes of each of the cells closest to the neck component are longitudinally aligned with each other.

### Claim 5

The neurovascular occlusion device of any one of the preceding claims, wherein the anchoring component is concave in a direction away from the concave occlusive component.

### Claim 6

The neurovascular occlusion device of any one of the preceding claims, wherein the support structure has an expansion ratio of at least about 8:1.

### Claim 7

The neurovascular occlusion device of any one of the preceding claims, wherein the expansion ratio is at least about 10:1.

### Claim 8

The neurovascular occlusion device of any one of the preceding claims, further comprising a functionally occlusive membrane without a guidewire lumen and carried by the occlusive component.

### Claim 9 (depends on 8)

The neurovascular occlusion device of claim 8, wherein the functionally occlusive membrane is configured to prevent at least 90% of fluid flow from flowing past the occlusion device at 120 mmHg pressure.

### Claim 10

The neurovascular occlusion device of any one of the preceding claims, further comprising elongate markers positioned at a proximal end and/or a distal end of the occlusion device, a major axis of the elongate markers extending in a longitudinal direction of the occlusion device.

### Claim 11 (depends on 10)

The neurovascular occlusion device of claim 10, wherein the elongate markers are rectangular.

### Claim 12

A neurovascular occlusion device for occluding blood flow in a vessel, comprising:
a support structure, self-expandable from a reduced cross-section for transluminal navigation to an enlarged cross-section for occluding a vessel, the support structure defining a concave occlusive component and an anchoring component separated by a neck component; the anchoring component comprising a ring of cells, each cell comprising a node that is closest to the neck component, the nodes being staggered such that each node is circumferentially and longitudinally offset from the node of a circumferentially adjacent cell and alternating nodes are longitudinally aligned with each other.

### Claim 13 (depends on 12)

The neurovascular occlusion device of claim 12, wherein the concave occlusive component comprises a ring of cells, each cell comprising a node closest to the neck component, the nodes being longitudinally aligned with each other.

### Claim 14 (depends on 12, 13)

The neurovascular occlusion device of claim 12 or 13, further comprising a functionally occlusive membrane without a guidewire lumen and carried by the occlusive component.

### Claim 15 (depends on 14)

The neurovascular occlusion device of claim 14, wherein the functionally occlusive membrane is configured to prevent more than 90% of fluid from flowing past the occlusion device at 120 mmHg pressure within three minutes.

### Claim 16 (depends on 14, 15)

The neurovascular occlusion device of claim 14 or 15, wherein the functionally occlusive membrane is porous and has no openings that are greater than a pore size of about 0.2 mm.

### Claim 17 (depends on 14, 15, 16)

The neurovascular occlusion device of any one of claims 14 to 16, wherein the functionally occlusive membrane has a same thickness along a length of the occlusive membrane.

### Claim 18 (depends on 17)

The neurovascular occlusion device of claim 17, wherein the functionally occlusive membrane comprises a region of curvature and a cylindrical region, the cylindrical region having a greater number of layers than the region of curvature.

### Claim 19 (depends on 14, 15, 16)

The neurovascular occlusion device of any one of claims 14 to 16, wherein the functionally occlusive membrane comprises a region of curvature and a cylindrical region, a thickness of the region of curvature being greater than a thickness of the cylindrical region.

### Claim 20 (depends on 12, 13, 14, 15, 16, 17, 18, 19)

The neurovascular occlusion device of any one of claims 12 to 19, wherein a thickness of the occlusive membrane is no greater than about 30 microns.

### Claim 21 (depends on 12, 13, 14, 15, 16, 17, 18, 19, 20)

The neurovascular occlusion device of any one of claims 12 to 20, wherein the anchoring component is concave in a direction away from the concave occlusive component.

### Claim 22 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21)

A method of occluding a vessel, the method comprising:
advancing a pusher assembly through an elongate tubular structure until an occlusion device of any one of claims 1 to 21 is positioned at a distal portion of the elongate tubular structure, the pusher assembly having an outer diameter of less than or equal to about 3F and comprising:
an interlock pusher configured to be axially advanced through the shuttle tube, the pusher assembly comprising a distal region, an intermediate region, a proximal region, and a lumen extending therethrough;
retracting the elongate tubular structure to release the occlusion device, the occlusion device comprising a first interference surface configured to interface with a second interference surface of the distal region of the interlock pusher until the occlusion device is released from the interlock pusher.

### Claim 23 (depends on 22)

The method of claim 22, further comprising retracting the anchoring component of the occlusion device prior to exposing the occlusive portion to blood flow.

### Claim 24 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21)

A system for occluding a vessel, the system comprising:
an elongate tubular structure;
a pusher assembly having an outer diameter of less than or equal to about 3F and comprising:
an interlock pusher configured to be axially advanced through the shuttle tube, the pusher assembly comprising a distal region, an intermediate region, a proximal region, and a lumen extending therethrough; and
an occlusion device of any one of claims 1 to 21, the occlusion device further comprising a first interference surface configured to interface with a second interference surface of the distal region of the interlock pusher until the occlusion device is released from the interlock pusher.

### Claim 25 (depends on 24)

The system of claim 24, wherein the intermediate region of the interlock pusher is more flexible than the proximal region to facilitate navigation through the vessel.

### Claim 26 (depends on 25)

The system of claim 25, wherein the intermediate region comprises a coil.

### Claim 27 (depends on 24, 25, 26)

The system of any one of claims 24 to 26, wherein the occlusion device further comprises a proximal marker positioned at a proximal end of the support structure, and wherein the proximal marker comprises the first interference surface.

### Claim 28 (depends on 24, 25, 26, 27)

The system of any one of claims 24 to 27, wherein the first interference surface is displaced from a proximal end of the occlusion device.

### Claim 29 (depends on 24, 25, 26, 27)

The system of any one of claims 24 to 27, wherein the first interference surface is positioned at a proximal end of the occlusion device.
